Across TCGA pan-cancer cohorts, FMO9P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated FMO9P data layer compared with 15 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher FMO9P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FMO9P expression acts as an unfavorable survival marker.

ESCA are the cancer types where FMO9P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.226	0.686	.013	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: FMO9P tumor-vs-normal RNA expression · all FMO9P data types